Lactose-conjugated PLGA nanoparticles for enhanced delivery of rifampicin to the lung for effective treatment of pulmonary tuberculosis

PDA Journal of Pharmaceutical Science and Technology

Volumn 64, Issue 3, 2010, Pages 278-287

  Jain, Sanjay K ^a   Gupta, Yashwant ^a   Ramalingam, Lathaeswari ^a   Jain, Anekant ^a   Jain, Aviral ^a   Khare, Piush ^a   Bhargava, Divya ^a  

^a DR H S GOUR UNIVERSITY   (India)

Author keywords

Lactose PLGA conjugate; Lung specific delivery; Nanoparticles; PLGA nanoparticles; Rifampicin

Indexed keywords

DRUG CARRIER; LACTOSE; NANOPARTICLE; POLYGLACTIN; RIFAMPICIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIALYSIS; DRUG BLOOD LEVEL; DRUG CONJUGATION; DRUG DOSAGE FORM COMPARISON; DRUG RELEASE; DRUG SOLUTION; DRUG TRANSPORT; DRUG UPTAKE; FLUORESCENCE ANALYSIS; INFRARED SPECTROSCOPY; LUNG PARENCHYMA; LUNG TUBERCULOSIS; MALE; NANOENCAPSULATION; NONHUMAN; PARTICLE SIZE; RAT; ZETA POTENTIAL; CHEMISTRY;

DRUG CARRIERS; LACTOSE; NANOPARTICLES; PARTICLE SIZE; RIFAMPIN; TUBERCULOSIS, PULMONARY;

EID: 78149333810     PISSN: 10797440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Deol, P.; Khuller, G. K. Lung specific stealth liposomes: stability, biodistribution and toxicity of liposomal antitubercular drugs in mice. Biochim. Biophys, Acta. 1997, 1334 (2-3), 161-172.
2. Teo, S. K. Assessment of a combined preparation of isoniazid, rifampicin and pyrazinamide in the initial phase of chemotherapy in three 6-month regimens for smear-positive pulmonary tuberculosis: a five-year follow-up report. Int. J. Tuberc. Lung Dis. 1999, 3 (2), 126-132.
3. Girgling, D. J. The hepatic toxicity of antituberculosis regimens containing isoniazi, rifampicin and pyrazinamide. Tubercle 1978, 59, 13-32.
4. Zierski, M.; Bek, E. Side effects of drug regimens used in short course chemotherapy for pulmonary tuberculosis: a controlled study. Tubercle 1980, 61, 41-49.
5. Barrow, E. L. W.; Winchester, G. A.; Staas, J. K.; Quenelled, D. C.; Barrow, W. W. Use of microsphere technology for targeted delivery of rifampin to mycobacterium tuberculosis-infected macrophages. Antimicrob. Agents Chemother. 1998, 42 (10), 2682-2689.
6. Dutt, M.; Khuller, G. K. Liposomes and PLG microparticles as sustained release antitubercular drug carriers - an in-vitro in-vivo study. Int. J. Antimicrob. Agents 2001, 18 (3), 245-252.
7. Sharma, R.; Saxena, D.; Dwivedi, A. K.; Misra, A. Inhalable microparticles containing drug combinations to target alveolar macrophages for treatment of pulmonary tuberculosis. Pharm. Res. 2001, 18 (10), 1405-1410.
8. Suarez, S.; O'Hara, P.; Kazantseva, M.; Newcomer, C. E.; Hopfer, R.; McMurray, D. N. Airways delivery of rifampicin microparticles for the treatment of tuberculosis. J. Antimicrob. Chemother. 2001, 48 (3), 431-434.
9. Denkbas, E. B.; Kaitian, X.; Tuncel, A.; Piskin, E. Rifampicin-carrying poly(d,l-lactide) microspheres: loading and release. J. Biomater. Sci. Polym. Ed. 1995, 6 (9), 815-825.
10. Pandey, R.; Sharma, A.; Zahoor, A.; Sharma, S.; Khuller, G. K.; Prasad, B. Poly (d,l-lactide-coglycolide) nanoparticle-based inhalable sustained drug delivery system for experimental tuberculosis. J. Antimicrob. Chemother. 2003, 52 (6), 981-986.
11. Pandey, R.; Sharma, S.; Khuller, G. K. Oral solid lipid nanoparticles based antitubercular chemotherapy. Tuberculosis 2005, 85 (5-6), 415-420.
12. Jain, R. A. The manufacturing techniques of various drug loaded biodegradable poly(lactide-coglycolide) devices. Biomaterials 2000, 21 (23), 2475-2490.
13. Soppimath, K. S.; Aminabhari, T. M.; Kulkarni, A. R.; Rudzinski, W. E. Biodegradable polymeric nanoparticles as drug delivery devices. J. Controlled Release 2001, 70 (1-2), 1-20.
14. Knight, C. G. Liposomes from Physical Structure to Therapeutic Applications. Elsevier: Amsterdam, 1981; pp 129-132.
15. Ogawa, Y.; Okada, H.; Heya, T.; Shimamoto, T. J. Controlled release of LHRH agonist, leuprolide acetate, from microcapsules: serum drug level profiles and pharmacological effects in animals. J. Pharm. Pharmacol. 1989, 41 (7), 439-444.
16. Derrien, D.; Midous, P.; Petit, C. Muramyl dipeptide bound to poly-L-lysine substituted with mannose and gluconoyl residues as macrophage activators. Glycoconj. J. 1989, 6 (2), 241-255.
17. Klink, D. T.; Glick, M. C.; Scanlin, T. F. Gene therapy of cystic fibrosis (CF) airways: A review emphasizing targeting with lactose. Glycoconj. J. 2001, 18 (9), 731-740.
18. Kollen, W. J. W.; Schembri, F. M.; Gerwig, G. J.; Vliegenthart, J. F. G.; Glick, M. C.; Scanlin, T. F. Enhanced efficiency of lactosylated poly-L-lysine-mediated gene transfer into cystic fibrosis airway epithelial cells. Am. J. Respir. Cell Mol. Biol. 1999, 20 (5), 1081-1086.
19. Yoon, J. J.; Nam, Y. S.; Kim, J. H.; Park, T. G. Surface immobilization of galactose onto aliphatic biodegradable polymers for hepatocyte culture. Biotechnol. Bioeng. 2002, 78 (1), 1-10.
20. Fessi, H.; Puisieux, F.; Devissaguet, J. P.; Ammoury, N.; Benita, S. Nanocapsule formation by interfacial polymer deposition following solvent displacement. Int. J. Pharm. 1989, 55 (1), R1-R4.
21. Musumeci, T.; Ventura, C. A.; Giannone, I.; Ruozi, B.; Montenegro, L.; Pignatello, R.; Puglisi, G. PLA/PLGA nanoparticles for sustained release of docetaxel. Int. J. Pharm. 2006, 325 (1-2), 172-179.
22. Pandey, R.; Khuller, G. K. Oral nanoparticlebased antituberculosis drug delivery to the brain in an experimental model. J. Antimicro. Chemother. 2006, 57 (6), 1146-1152.
23. Gupta, Y.; Soni, V.; Chourasia, M. K.; Jain, A.; Khare, P.; Jain, S. K. Targeted drug delivery to the brain via transferrin coupled liposomes. Drug Deliv. Tech. 2005, 5, 66-71.
24. Chan, K. Rifampicin concentration in cerebrospinal fluid and plasma of the rabbit by high performance liquid chromatography. Methods Find. Exp. Clin. Pharmacol. 1986, 8 (12), 721-726.
25. Gupta, Y.; Jain, A.; Jain, S. K. Transferrin-conjugated solid lipid nanoparticles for enhanced delivery of quinine dihydrochloride to the brain. J. Pharm. Pharmacol. 2007, 59 (7), 1-6.
26. Choi, S. W.; Kwon, H. Y.; Kim, W. S.; Kim, J. H. Thermodynamic parameters on poly(d,l-lactide-co-glycolide) particle size in emulsification diffusion process. Colloids Surf. Physicochem. Eng. 2002, 201 (1-3), 283-289.
27. Holland, S. J.; Tighe, B. J. Biodegradable Polymers. In Advanced Pharmaceutical Sciences; Garderton, D., Jones, T., Eds.; Academic Press: New York, 1992; Vol. 6; pp 101-164.
28. Makino, K.; Nakajima, T.; Shikamura, M.; Ito, F.; Ando, S.; Kochi, C.; Inagawa, H.; Soma, G.; Terada, H. Efficient intracellular delivery of rifampicin to alveolar macrophages using rifampicin-loaded PLGA microspheres: effects of molecular weight and composition of PLGA on release of rifampicin. Colloids Surf. B. Biointerfaces 2004, 36 (1), 35-42.
29. Ito, F.; Makino, K. Preparation and properties of monodispersed rifampicin-loaded poly(lactide-co-glycolide) microspheres. Colloids Surf. B. Biointerfaces 2004, 39 (1-2), 17-21.
30. Gupta, Y.; Jain, A.; Jain, P.; Jain, S. K. Design and development of folate appended liposomes for enhanced delivery of 5-FU to tumour cells. J. Drug Target 2007, 15 (3), 231-240.